UNC?1021
CAS No. 1322591-19-4
UNC?1021( —— )
Catalog No. M35814 CAS No. 1322591-19-4
UNC 1021 is a selective L3MBTL3 inhibitor (IC50 = 0.048 μM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 36 | In Stock |
|
| 10MG | 55 | In Stock |
|
| 25MG | 107 | In Stock |
|
| 50MG | 166 | In Stock |
|
| 100MG | 267 | In Stock |
|
| 200MG | 369 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameUNC?1021
-
NoteResearch use only, not for human use.
-
Brief DescriptionUNC 1021 is a selective L3MBTL3 inhibitor (IC50 = 0.048 μM).
-
DescriptionUNC1021 is a selective L3MBTL3 inhibitor with an IC50 of 0.048 μM.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
RecptorEpigenetic Reader Domain
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1322591-19-4
-
Formula Weight438.61
-
Molecular FormulaC26H38N4O2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : ≥ 9.09 mg/mL (20.72 mM )
-
SMILESO=C(N1CCC(CC1)N1CCCC1)c1ccc(cc1)C(=O)N1CCC(CC1)N1CCCC1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. James LI, et al. Small-molecule ligands of methyl-lysine binding proteins: optimization of selectivity for L3MBTL3. J Med Chem. 2013 Sep 26;56(18):7358-71.?
molnova catalog
related products
-
AW68
AW68 is a potential small molecule BRD4 inhibitor that prevents and treats BRD4-related diseases and can be used in cancer research.
-
GSK046
GSK046 is a potent, selective and orally active BD2 bromodomain inhibitor of the BET proteins(IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively).
-
FHT-1015
FHT-1015 is a potent SMARCA4/SMARCA2 ATPase (BRG1 and BRM) inhibitor with potential anticancer activity for the study of cancer and inflammation.
Cart
sales@molnova.com